Skip to content

HEMO-INTEGRA: Integrated Intraoperative Hemodynamic Monitoring During Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Study

HEMO-INTEGRA: Feasibility and Description of an Integrated Intraoperative Hemodynamic Monitoring System for Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07683299
Acronym
HEMO-INTEGRA
Enrollment
30
Registered
2026-07-06
Start date
2026-05-27
Completion date
2027-03-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Cardiopulmonary Bypass, Hemodynamic Monitoring, Ventricular-Arterial Coupling

Keywords

HEMO-INTEGRA, VExUS, Oxygen Delivery, NIRS, Deep Hypothermia, Transesophageal Echocardiography, Clinical Decision Support

Brief summary

HEMO-INTEGRA is a software system that integrates four domains of intraoperative hemodynamic monitoring in a single dashboard during cardiac surgery with cardiopulmonary bypass (CPB): (1) ventricular-arterial coupling (VAC) analysis using the Balan 2026 method; (2) tissue perfusion and oxygen delivery (EPOC module with Q10 temperature correction); (3) neuromonitoring (NIRS/BIS); and (4) systemic venous congestion assessment via VExUS-TEE (Waldron 2024 method). This pilot observational study evaluates the feasibility and completeness of data capture using HEMO-INTEGRA across five perioperative time points (T0: pre-CPB; T1: early CPB; T2: mid-CPB; T3: rewarming; T4: post-CPB) in adult patients undergoing elective cardiac surgery at Clinica Medellin Sede Occidente, Medellin, Colombia. The system operates in parallel with standard monitoring and does not modify clinical management. No additional procedures are performed on participants beyond standard of care.

Interventions

None listed

Sponsors

Hernán Darío Castro Arias
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \- Adult patients 18 years or older scheduled for elective cardiac surgery with cardiopulmonary bypass * Standard intraoperative TEE and arterial line monitoring in place * Written informed consent obtained

Exclusion criteria

* \- Emergency surgery * Off-pump cardiac surgery (OPCAB) * Inability to obtain adequate TEE window * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Data Capture CompletenessIntraoperative (0 to 6 hours)Proportion of cases with complete data capture across all five intraoperative time points (T0 to T4) for all four HEMO-INTEGRA monitoring modules: ventricular-arterial coupling, tissue perfusion, neuromonitoring, and venous congestion assessment.

Countries

Colombia

Contacts

CONTACTHernan D Castro-Arias, MD MSc
hernan_castro@icloud.com+573128633884
PRINCIPAL_INVESTIGATORHernan D Castro-Arias, MD MSc

Clinica Medellin Sede Occidente, Grupo Quiron Salud

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026